Mutant p53, in combination with NF-κB, can therefore alter the inflammatory tumor microenvironment (TME), inducing in both epithelial and and non-epithelial cells the expression of cancer-promoting gene (Fig. 3) [107]. The gene discussed is TP53; the disease is cancer.